RICHARD A RUDICK, MD
Neurology at Euclid Ave, Cleveland, OH

License number
Ohio 35054570
Category
Neurology
Type
Neurology
Address
Address
9500 Euclid Ave, Cleveland, OH 44195
Phone
(800) 223-2273

Personal information

See more information about RICHARD A RUDICK at radaris.com
Name
Address
Phone
Richard Rudick, age 73
5067 Boulder Creek Dr, Solon, OH 44139
(440) 349-4414
Richard Rudick
991 Powers Ave, Girard, OH 44420
(330) 759-2158
Richard Rudick
Chagrin Falls, OH
(440) 349-4414
Richard A Rudick
17325 Euclid Ave, Cleveland, OH 44112
(216) 444-8603
Richard A Rudick, age 74
5067 Boulder Creek Dr, Solon, OH 44139
(440) 349-4414

Organization information

See more information about RICHARD A RUDICK at bizstanding.com

Richard Rudick MD

9500 Euclid Ave, Cleveland, OH 44195

Industry:
Neurologist, Internist
Phone:
(216) 444-5559 (Phone)
Description:
There are 56 doctors at this site. Surgery is not performed at this site.
Richard Alan Rudick


Cleveland Clinic Foundation - Richard A Rudick MD

9500 Euclid Ave #U10, Cleveland, OH 44195

Categories:
Neurology Physicians & Surgeons, Physicians & Surgeons
Phone:
(216) 444-8603 (Phone)

Professional information

Richard A Rudick Photo 1

Dr. Richard A Rudick, Cleveland OH - MD (Doctor of Medicine)

Specialties:
Internal Medicine, Neurology
Address:
CLEVELAND CLINIC FOUNDATION
9500 Euclid Ave, Cleveland 44195
(440) 519-6880 (Phone)
Mellen Center
9500 Euclid Ave SUITE U10, Cleveland 44195
(216) 444-8603 (Phone)
CLEVELAND CLINIC FOUNDATION
9500 Euclid Ave, Cleveland 44195
(216) 445-6249 (Phone), (216) 445-6249 (Fax)
CLEVELAND CLINIC FOUNDATION
9500 Euclid Ave, Cleveland 44195
(216) 444-4324 (Phone), (216) 444-2536 (Fax)
CLEVELAND CLINIC FOUNDATION
9500 Euclid Ave, Cleveland 44195
(216) 444-8091 (Phone), (216) 445-1076 (Fax)
CLEVELAND CLINIC FOUNDATION
9500 Euclid Ave, Cleveland 44195
(216) 444-9083 (Phone), (216) 444-8575 (Fax)
Certifications:
Internal Medicine, 1978, Neurology, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
CLEVELAND CLINIC FOUNDATION
9500 Euclid Ave, Cleveland 44195
CLEVELAND CLINIC FOUNDATION
9500 Euclid Ave, Cleveland 44195
CLEVELAND CLINIC FOUNDATION
9500 Euclid Ave, Cleveland 44195
CLEVELAND CLINIC FOUNDATION
9500 Euclid Ave, Cleveland 44195
CLEVELAND CLINIC FOUNDATION
9500 Euclid Ave, Cleveland 44195
Mellen Center
9500 Euclid Ave SUITE U10, Cleveland 44195
Cleveland Clinic
9500 Euclid Ave, Cleveland 44195
Education:
Medical School
Case Western Reserve Univ Sch Of Med
Graduated: 1975
U Conn Hlth Ctr
Strong Memorial Hospital
U Rochester


Richard Rudick Photo 2

Md At Cleveland Clinic

Position:
MD at Cleveland Clinic
Location:
Cleveland/Akron, Ohio Area
Industry:
Medical Practice
Work:
Cleveland Clinic - MD


Richard Rudick Photo 3

Method And System For Brain Volume Analysis

US Patent:
6366797, Apr 2, 2002
Filed:
Aug 24, 1999
Appl. No.:
09/382056
Inventors:
Elizabeth Fisher - Cleveland Heights OH
Richard A. Rudick - Solon OH
Assignee:
The Cleveland Clinic Foundation - Cleveland OH
International Classification:
A61B 500
US Classification:
600410, 382128, 128922
Abstract:
A method of analyzing medical image data to measure brain atrophy and determine the severity and progression of multiple sclerosis or other condition which leads to neurodegeneration or axonal damage is provided. Magnetic resonance image data representing a brain of a subject is provided and a brain surface contour is automatically identified by separating the brain from other connected structures in the image data. A total volume within the brain surface contour is calculated. A brain volume is then determined within the surface contour which excludes fluid filled regions and accounts for partial volume effects. The brain volume is then normalized by the total contour volume which generates a brain parenchymal fraction. The brain parenchymal fraction serves as a reliable measurement of brain atrophy and assists in determining the severity and progression of multiple sclerosis or other condition which leads to neurodegeneration or axonal damage.


Richard Rudick Photo 4

Method For Predicting A Therapy Response In Subjects With Multiple Sclerosis

US Patent:
2013008, Apr 11, 2013
Filed:
Jun 17, 2011
Appl. No.:
13/704752
Inventors:
Richard A. Rudick - Solon OH, US
Richard M. Ransohoff - Shaker Heights OH, US
International Classification:
C12Q 1/68
US Classification:
424 856, 506 9
Abstract:
A method is provided for determining the efficacy of interferon-beta (IFN-β) therapy in a subject with multiple sclerosis. One step of the method can include obtaining a biological sample from the subject. After obtaining the biological sample, the expression level of at least one interferon-regulated gene (IRG) and/or variant thereof can be determined. Increased or decreased expression of the at least one IRG and/or variant thereof as compared to a control may indicate that the subject will respond poorly to IFN-β therapy.